HNGZY Stock Price, Chart, Stats & News

Hangzhou Tigermed Consulting Co., Ltd (HNGZY) is a dividend-paying stock with a current dividend yield of 0.29% as of Aug 13, 2026. It pays $0.0130 per share over the trailing twelve months and distributes annually.
Dividend safety
Dividend coverage looks healthy — HNGZY pays out about 11% of earnings.
HNGZY chart
About
Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People's Republic of China and internationally. The company offers clinical trial operation services, such as clinical pharmacology, registration and regulatory affairs, scientific affairs, medical translation, pharmacovigilance, real-world research, third-party auditing and training, etc. for innovative drugs, generic drugs, and medical devices, as well as supporting services directly related to clinical trials, including clinical operation, clinical trials, and clinical trials management. It also provides clinical trial related and laboratory services in the drug development process comprising data management and statistical analysis, clinical trial site management, subject recruitment, medical imaging, and laboratory services.
Related lists
Similar securities
Based on sector and market capitalization





